"My colleagues are some of the greatest humanitarians I've ever known."
-Igho Ofotokun, MD, FIDSA
Pain has always been an important part of human immunodeficiency virus (HIV) disease and its experience for patients. In this guideline, we review the types of chronic pain commonly seen among persons living with HIV (PLWH) and review the limited evidence base for treatment of chronic noncancer pain in this population. We also review the management of chronic pain in special populations of PLWH, including persons with substance use and mental health disorders. Finally, a general review of possible pharmacokinetic interactions is included to assist the HIV clinician in the treatment of chronic pain in this population.
As the new Congress begins its session, the federal government remains partially closed with funding for key global health programs in limbo. Programs across the U.S. Department of State and the U.S. Agency for International Development are without funding allocations for 2019, including PEPFAR and USAID’s global TB program.
Learn MoreSave the date for IDWeek 2019, the combined annual meeting of IDSA, SHEA, HIVMA, and PIDS, which will be held October 2-6, 2019 in Washington, DC.
Member Registration will open on March 5, 2019. Registration will open to everyone on April 2, 2019.